HPV and Oral Cancer
FDA Approves HPV Vaccine For Men And Women Aged 27 To 45.
The New York Times (10/5, Grady, Hoffman) reported that the Food and Drug Administration has approved the HPV vaccine “for men and women from 27 to 45-years-old.” The article noted that the vaccine “had been previously approved for minors and people up to age 26.” The HPV vaccine “works against the human papillomavirus, HPV, which can also cause genital warts and cancers” including “tumors affecting part of the throat – called oropharyngeal cancers” which are on the rise.
CNN (10/5, Lamotte) reported that Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said, “HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing.”
The Washington Post (10/5, McGinley) reported that the approval “represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range,” said Dr. Marks.
HPV is linked to Oral Cancer and oral cancer is on the rise in the US- we complete a visual inspection for oral cancer at each visit and once a year we use our Velscope machine for a more in depth screening. This screening is quick and painless!